Category Archives: Other

Guangdong Unifies Medical Device Listing Process for May 2025 Batch

GUANGZHOU — Guangdong Province has announced the standardization of its medical device listing process, aiming to streamline the procurement and management of medical consumables. The first batch of newly listed products for May 2025 has been published, marking a significant step toward a unified and transparent procurement system.

Policy Breakdown

Unified Listing Process: The Guangdong Provincial Medical Device Exchange Center has released the first batch of medical devices under the new unified listing process. This batch, designated as GDHCTYGW01-20250501, includes various medical consumables that have been reviewed and approved for inclusion in the provincial procurement system.
Operational Details: Companies can log in to the Guangdong Medical Device Procurement Subsystem using their CA certificates to view the listing results and manage distribution relationships. The new system ensures that all listed products are centrally managed under a unified catalog.
Implementation Timeline: The new listing process will be applied to all future batches, with the goal of creating a standardized and efficient procurement environment. The first batch of products will be available for contract transactions immediately, provided that distribution relationships are properly maintained.
Regulatory Requirements: To facilitate smooth transactions, companies are urged to complete distribution relationship maintenance as soon as possible. Detailed operational guidelines are available on the official website under “Member Services – Business Guidelines.”

Industry Impact

Efficiency Gains: The unified listing process is expected to reduce administrative burdens and improve the efficiency of medical device procurement for healthcare providers.
Market Transparency: Standardizing the listing process enhances transparency, making it easier for companies to navigate the procurement system and ensuring fair competition.
Quality Assurance: The centralized management of listed products ensures that only high-quality and compliant medical devices are procured, benefiting both healthcare providers and patients.

Looking Ahead
Stakeholders, including medical device manufacturers and healthcare institutions, should familiarize themselves with the new listing process and operational requirements. The long-term goal is to create a more efficient and transparent procurement environment, ultimately improving the quality and availability of medical devices in Guangdong.-China Health Reform Pulse

For detailed implementation guidelines and the full list of approved products, refer to the official announcements from the Guangdong Provincial Medical Device Exchange Center.

Policy Source: https://www.gdmede.com.cn/announcement/announcement/detail?id=1927162319360495616

Yunnan Launches Centralized Procurement for Biochemical Reagents

KUNMING — Yunnan Province has introduced a centralized procurement policy for biochemical reagents, including those for sugar metabolism tests, aimed at optimizing the supply chain and reducing costs for healthcare providers. The policy, which takes effect on June 5, 2025, will be implemented over a two-year cycle, with the potential for a one-year extension.

Policy Breakdown

Procurement Entities: The policy covers public medical institutions, including military hospitals and private institutions designated by the medical insurance system. Other healthcare providers are also encouraged to participate.
Product Scope: The centralized procurement will focus on reagents listed in the “Sugar Metabolism and Biochemical Reagent Centralized Procurement List” (available in the appendix).
Execution Timeline: The procurement cycle will last for two years, with annual agreements signed between medical institutions, manufacturers, and distributors.
Agreement Volumes: The agreed-upon procurement volumes will be determined through the Jiangxi Province Medical Security Information Platform and imported into Yunnan’s Medical Security Information Platform.
Implementation Requirements:
Priority for Selected Products: Medical institutions are required to prioritize the use of selected products while ensuring the completion of agreed procurement volumes.
Supply and Distribution: Selected manufacturers must ensure product quality and supply, partnering with reliable distributors to meet the needs of medical institutions.
Non-Selected Products: Products not included in the centralized procurement list must follow the dynamic pricing and listing requirements outlined in the “Yunnan Province Medicines and Medical Consumables Dynamic Listing Plan” (Yun Medical Insurance [2022] No. 92).
Regulatory Oversight: The medical insurance department will collaborate with other regulatory bodies to monitor the procurement and use of selected products, taking punitive measures against non-compliant manufacturers and distributors.

Industry Impact

Cost Efficiency: Centralized procurement is expected to reduce costs for medical institutions, ultimately benefiting patients through lower healthcare expenses.
Market Consolidation: The policy may lead to market consolidation, with selected manufacturers gaining a competitive edge. Non-selected companies may face challenges in market access.
Quality Assurance: The emphasis on quality control and regulatory oversight ensures that only high-quality reagents are procured through the centralized system.

Looking Ahead
Stakeholders, including reagent manufacturers and healthcare providers, should closely monitor the implementation of the centralized procurement policy. The long-term goal is to enhance the efficiency and transparency of the procurement process while maintaining high standards of medical supplies.-China Health Reform Pulse

For detailed implementation guidelines and the full procurement list, refer to the official announcements from the Yunnan Provincial Medical Security Bureau.

Policy Source: http://www.ynyyzb.com.cn/detail.html?infoId=25514&CatalogId=3

Yunnan Implements Centralized Procurement for Biochemical Reagents

KUNMING — Yunnan Province has initiated a centralized procurement program for biochemical reagents, specifically targeting products related to sugar metabolism and other biochemical tests. The policy aims to streamline the procurement process, reduce costs, and ensure the availability of high-quality medical reagents across the region.

Policy Breakdown

Centralized Procurement: The policy mandates that selected products from the “Sugar Metabolism and Biochemical Reagent Centralized Procurement List” will be available for purchase through Yunnan’s Medical Security Information Platform.
Implementation Timeline: The centralized procurement will take effect on June 5, 2025, with a procurement cycle of two years.
Distribution and Contracting: Selected companies will be required to establish distribution relationships through the platform, signing tripartite agreements annually to clarify rights and responsibilities.
Non-Selected Products: Products not included in the centralized procurement list will follow the dynamic pricing and listing requirements outlined in the “Yunnan Province Medicines and Medical Consumables Dynamic Listing Plan” (Yun Medical Insurance [2022] No. 92).

Industry Impact

Cost Reduction: The centralized procurement model is expected to drive down costs for biochemical reagents, benefiting both healthcare providers and patients.
Market Consolidation: Companies that fail to secure a place in the centralized procurement list may face challenges in market access, while selected companies will gain a competitive edge.
Quality Assurance: The policy emphasizes the importance of quality control, ensuring that only high-standard products are procured through the centralized system.

Looking Ahead
Stakeholders, including reagent manufacturers and healthcare providers, should closely monitor the implementation of the centralized procurement policy. The long-term goal is to enhance the efficiency and transparency of the procurement process while maintaining high standards of medical supplies.-China Health Reform Pulse

For detailed implementation guidelines and the full procurement list, refer to the official announcements from the Yunnan Provincial Government Procurement and Disposal Center.

Policy Source: http://www.ynyyzb.com.cn/detail.html?infoId=25515&CatalogId=3